or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    AKBA F Akebia Therapeutics, Inc. 0.43
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    ARDX C Ardelyx, Inc. 0.00
    AZN A Astrazeneca PLC 0.00
    BAX F Baxter International Inc. -0.06
    CALT D Calliditas Therapeutics AB 0.00
    CYCN D Cyclerion Therapeutics, Inc. 0.00
    CTSO D Cytosorbents Corporation 0.00
    DMAC C DiaMedica Therapeutics Inc. 0.00
    FGEN F FibroGen, Inc 0.00
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Renal Disease Anemia Biotechnology End Stage Renal Disease Life Sciences Medicine Stage Renal Disease Cancer Clinical Development Diabetic Nephropathy Dialysis Disease Dysfunction Gastrointestinal Heart Failure Hypoxia Inducible Factors Inflammation Inflammation Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 5.86
    MEDX D Horizon Kinetics Medical ETF 5.71
    IBBQ B Invesco Nasdaq Biotechnology ETF 4.81
    FLUD A Franklin Liberty Ultra Short Bond ETF 4.07
    BIB C ProShares Ultra Nasdaq Biotechnology 3.31
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare MEDX to IBBQ Compare PPH to BIB Compare PPH to FLUD

        Kidney Disease Stocks Recent News

        Date Stock Title
        May 21 AZN AstraZeneca projects $80B in revenue by 2030
        May 21 AZN AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion
        May 21 AZN Trending tickers: Trump Media, Palo Alto, AstraZeneca and Kingfisher
        May 21 AZN AstraZeneca to establish $1.5bn ADC production site in Singapore
        May 21 AZN Lowe's, Macy's, Xpeng rise premarket; Palo Alto, Zoom fall
        May 21 AZN AstraZeneca Targets $80 Billion Revenue by 2030 Through Pipeline Expansion
        May 21 AZN AstraZeneca shares rise as pharma group unveils 2030 revenue target
        May 21 AZN AstraZeneca aims for $80 billion in total revenue by 2030
        May 21 AZN AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
        May 21 AZN European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
        May 20 AZN Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
        May 20 AZN Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
        May 20 AZN AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
        May 20 AZN AstraZeneca to build $1.5B ADC manufacturing plant in Singapore
        May 20 AZN AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
        May 20 AZN Trending tickers: Gold, Ryanair, Nvidia and AstraZeneca
        May 20 AZN AstraZeneca to build $1.5bn ADCs facility in Singapore
        May 20 AZN Pfizer wins cancer drug patent case against AstraZeneca
        May 20 AZN AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore
        May 19 AZN New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Chronic Kidney Disease Renal Disease Anemia Biotechnology End Stage Renal Disease Life Sciences Medicine Stage Renal Disease Cancer Clinical Development Diabetic Nephropathy Dialysis Disease Dysfunction Gastrointestinal Heart Failure Hypoxia Inducible Factors Inflammation Inflammation Diseases
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags